LITHIUM Side Effects

6957779-4 | Asthenia, Dysarthria, Dyskinesia, Therapeutic Agent Toxicity, Tremor, Urinary Tract Infection
on Aug 30, 2010 Male patient from UNITED STATES , 59 years of age, weighting 200.6 lb, was diagnosed with schizoaffective disorder and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dysarthria, dyskinesia, therapeutic agent toxicity, tremor, urinary tract infection (What is urinary tract infection?). Lithium dosage: 300-600 Mg Bid Po. Patient was hospitalized.

6822124-1 | Nodal Arrhythmia, Therapeutic Agent Toxicity
Patient was taking Lithium (View Usage). Patient had the following side effects: nodal arrhythmia, therapeutic agent toxicity on Jul 06, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 160.0 lb, was diagnosed with mania and. Lithium dosage: . Patient was hospitalized.

6765311-3 | Ataxia
Adverse event was reported on Jun 10, 2010 by a Male patient taking Lithium (View Usage) (Dosage: 900 Mg At Bedtime Po) was diagnosed with affective disorder and. Location: UNITED STATES , 55 years of age, After Lithium was administered, patient had the following side effects: ataxia (What is ataxia?). Patient was hospitalized.

6765058-3 | Acute Prerenal Failure, Blood Creatinine Increased, Blood Urea Increased, Confusional State, Gait Disturbance, Mental Status Changes, Musculoskeletal Disorder
on Jun 09, 2010 Female patient from UNITED STATES , 59 years of age, weighting 168.9 lb, was diagnosed with schizoaffective disorder and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, blood creatinine increased, blood urea increased, confusional state, gait disturbance, mental status changes, musculoskeletal disorder. Lithium dosage: 300 Mg Bid Po. Patient was hospitalized.


6765057-1 | Aphasia, Dysarthria, Gait Disturbance, Tremor
on Jun 09, 2010 Male patient from UNITED STATES , 60 years of age, weighting 235.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), mania and was treated with Lithium (View Usage). Patient had the following side effects: aphasia (What is aphasia?), dysarthria, gait disturbance, tremor. Lithium dosage: 900 Mg At Bedtime Po. Patient was hospitalized.

6669386-1 | Abdominal Tenderness, Eosinophil Count Abnormal, Hyperaesthesia, Lymphadenopathy, Oral Disorder, Pain, Pharyngitis, Pruritus
Patient was taking Lithium (View Usage). After Lithium was administered, patient had the following side effects: abdominal tenderness, eosinophil count abnormal, hyperaesthesia, lymphadenopathy, oral disorder, pain (What is pain?), pharyngitis, pruritus on Apr 01, 2010 from UNITED STATES Additional patient health information: Female patient , 41 years of age, was diagnosed with depression (What is depression?) and. Lithium dosage: .

6669385-X | Abdominal Tenderness, Eosinophil Count Abnormal, Hepatic Enzyme Increased, Lymphadenopathy, Oral Disorder, Pain, Pharyngitis, Pruritus
Adverse event was reported on Apr 01, 2010 by a Female patient taking Lithium (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 41 years of age, Patient experienced the following unwanted or unexpected effects: abdominal tenderness, eosinophil count abnormal, hepatic enzyme increased, lymphadenopathy, oral disorder, pain (What is pain?), pharyngitis, pruritus.

6614534-2 | Agitation, Asthenia, Balance Disorder, Blood Calcium Increased, Blood Potassium Decreased, Blood Sodium Decreased, Confusional State, Diarrhoea
on Mar 04, 2010 Male patient from UNITED STATES , 53 years of age, weighting 163.1 lb, was treated with Lithium (View Usage). Patient had the following side effects: agitation, asthenia, balance disorder, blood calcium increased, blood potassium decreased, blood sodium decreased, confusional state, diarrhoea. Lithium dosage: 900 Mg Bid Po. Patient was hospitalized.

6614224-6 | Confusional State, Delirium, Hypovolaemia, Overdose, Parkinsonism, Renal Failure Acute, Tremor
on Mar 03, 2010 Male patient from UNITED STATES , 67 years of age, weighting 157.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), mania, schizoaffective disorder and was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: confusional state, delirium, hypovolaemia, overdose, parkinsonism, renal failure acute, tremor. Lithium dosage: 300 Mg Bid Po. Patient was hospitalized.

6583391-5 | Dehydration, Gastroenteritis, Renal Failure Acute, Therapeutic Agent Toxicity, Tremor
Patient was taking Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, gastroenteritis (What is gastroenteritis?), renal failure acute, therapeutic agent toxicity, tremor on Feb 12, 2010 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 200.2 lb, was diagnosed with bipolar i disorder and. Lithium dosage: 300 Mg Tid Po. Patient was hospitalized.

6582314-2 | Confusional State, Dehydration, Dizziness, Nausea, Renal Failure Acute, Tremor
Adverse event was reported on Feb 12, 2010 by a Male patient taking Lithium (View Usage) (Dosage: 450 Mg Bid Po) was diagnosed with bipolar i disorder and. Location: UNITED STATES , 51 years of age, weighting 262.6 lb, Patient had the following side effects: confusional state, dehydration, dizziness (What is dizziness?), nausea (What is nausea?), renal failure acute, tremor.

6554046-8 | Aphasia, Dysphagia, Gait Disturbance, Tremor
on Jan 21, 2010 Female patient from NETHERLANDS , weighting 231.5 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: aphasia (What is aphasia?), dysphagia, gait disturbance, tremor. Lithium dosage: . Patient was hospitalized.

6424064-9 | Rhabdomyolysis
on Oct 19, 2009 Male patient from TAIWAN, PROVINCE OF CHINA , 29 years of age, was diagnosed with schizoaffective disorder and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Lithium dosage: 600 Mg/day. During the same period patient was treated with CLOZAPINE (125-200 Mg/day) (View Clozapine Review and Clozapine Label ), VALPROIC ACID (1500 Mg/day) (View Valproic Acid Review and Valproic Acid Label ).

6423877-7 | Bradycardia, Hypotension, Loss Of Consciousness
Patient was taking Lithium (View Usage). Patient had the following side effects: bradycardia, hypotension, loss of consciousness on Oct 30, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 170.0 lb, was diagnosed with bipolar i disorder, hypertension and. Lithium dosage: 300 Mg Bid Po. During the same period patient was treated with METOPROLOL TARTRATE (25 Mg Bid Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6379758-0 | Lactic Acidosis, Renal Failure Acute
Adverse event was reported on Sep 14, 2009 by a Male patient taking Lithium (View Usage) (Dosage: Dosage Not Stated) was diagnosed with suicide attempt and. Location: FRANCE , 45 years of age, After Lithium was administered, patient had the following side effects: lactic acidosis, renal failure acute. During the same period patient was treated with METFORMIN HYDROCHLORIDE (Dosage Not Stated) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6346875-0 | Abnormal Behaviour, Balance Disorder, Fluid Imbalance, Nausea
on Sep 09, 2009 Male patient from UNITED STATES , 57 years of age, weighting 167.4 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), mania and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, balance disorder, fluid imbalance, nausea (What is nausea?). Lithium dosage: 300 Mg Bid Po. Patient was hospitalized.

6222088-8 | Intentional Overdose
on Jun 09, 2009 Male patient from FRANCE , 64 years of age, was diagnosed with bipolar i disorder and was treated with Lithium (View Usage). Patient had the following side effects: intentional overdose. Lithium dosage: . During the same period patient was treated with ZOLMITRIPTAN (View Zolmitriptan Review and Zolmitriptan Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ).

6177874-X | Agitation, Blood Potassium Decreased, Confusional State, Delirium, Electrocardiogram Q Waves, Incorrect Dose Administered, Mental Status Changes, Nausea
Patient was taking Lithium (View Usage). After Lithium was administered, patient had the following side effects: agitation, blood potassium decreased, confusional state, delirium, electrocardiogram q waves, incorrect dose administered, mental status changes, nausea (What is nausea?) on May 01, 2009 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 195.1 lb, was diagnosed with bipolar i disorder and. Lithium dosage: 600 Mg Hs Po. Patient was hospitalized.

5960003-2 | Oedema Peripheral, Pain In Extremity, Skin Discolouration, Treatment Noncompliance
Adverse event was reported on Nov 19, 2008 by a Female patient taking Lithium (View Usage) (Dosage: 300mg Po Qam, 600mg Qpm) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 58 years of age, weighting 192.5 lb, Patient experienced the following unwanted or unexpected effects: oedema peripheral, pain in extremity, skin discolouration, treatment noncompliance. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

5952491-2 | Blood Creatinine Increased, Intentional Overdose, Oliguria, Suicide Attempt, Therapeutic Agent Toxicity
on Nov 03, 2008 Female patient from ITALY , 47 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Lithium (View Usage). Patient had the following side effects: blood creatinine increased, intentional overdose, oliguria, suicide attempt, therapeutic agent toxicity. Lithium dosage: Text:40 Tablets. During the same period patient was treated with CLONAZEPAM (Text:20 Ml) (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

5942419-3 | Cerebellar Atrophy, Nervous System Disorder
on Oct 27, 2008 Female patient from BRAZIL , 26 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: cerebellar atrophy, nervous system disorder. Lithium dosage: Daily Dose:1500mg. Patient was hospitalized.

5936259-9 | Serotonin Syndrome
Patient was taking Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome on Oct 21, 2008 from SINGAPORE Additional patient health information: Male patient , 53 years of age, was diagnosed with mood swings, depression (What is depression?) and. Lithium dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), DOTHIEPIN (View Dothiepin Review and Dothiepin Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

5933335-1 | Autoimmune Thyroiditis, Encephalopathy
Adverse event was reported on Oct 16, 2008 by a Female patient taking Lithium (View Usage) (Dosage: Daily Dose:600mg-freq:frequency: Daily) . Location: JAPAN , 61 years of age, Patient had the following side effects: autoimmune thyroiditis, encephalopathy. During the same period patient was treated with FLUVOXAMINE MALEATE (Daily Dose:150mg-freq:frequency: Daily) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), LEVOTHYROXINE SODIUM (Daily Dose:.125mg-freq:frequency: Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

5921641-6 | Depression, Diarrhoea, Electrocardiogram Qt Prolonged, Electrocardiogram T Wave Amplitude Decreased, Hypophagia, Nausea, Renal Failure Chronic, Therapeutic Agent Toxicity, Tremor
on Oct 16, 2008 Male patient from UNITED STATES , 65 years of age, was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: depression (What is depression?), diarrhoea, electrocardiogram qt prolonged, electrocardiogram t wave amplitude decreased, hypophagia, nausea (What is nausea?), renal failure chronic, therapeutic agent toxicity, tremor. Lithium dosage: .

5918049-6 | Demyelination, Diabetes Insipidus
on Oct 02, 2008 Female patient from FRANCE , 23 years of age, was diagnosed with depression (What is depression?) and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: demyelination, diabetes insipidus (What is diabetes insipidus?). Lithium dosage: Daily Dose:750mg. Patient was hospitalized.

5663199-5 | Hypertension, Radical Prostatectomy, Renal Impairment
Patient was taking Lithium (View Usage). Patient had the following side effects: hypertension, radical prostatectomy, renal impairment on Mar 01, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 175.4 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), hypertension and. Lithium dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MOBAN (View Moban Review and Moban Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

5574664-3 | Confusional State, Haemodialysis, Sedation
Adverse event was reported on Dec 26, 2007 by a Male patient taking Lithium (View Usage) (Dosage: 600mg Bid Po) was diagnosed with schizoaffective disorder and. Location: UNITED STATES , 55 years of age, After Lithium was administered, patient had the following side effects: confusional state, haemodialysis, sedation. Patient was hospitalized.

5567939-5 | Therapeutic Agent Toxicity
on Dec 18, 2007 Male patient from UNITED STATES , 51 years of age, weighting 175.0 lb, was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: therapeutic agent toxicity. Lithium dosage: 300mg Bid Po. During the same period patient was treated with CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), BENZTROPINE (View Benztropine Review and Benztropine Label ), LITHOBID (View Lithobid Review and Lithobid Label ).

5500845-0 | Diarrhoea, Therapeutic Agent Toxicity
on Oct 24, 2007 Female patient from UNITED KINGDOM , 52 years of age, weighting 198.4 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), obesity (What is obesity?), hypothyroidism, insomnia and was treated with Lithium (View Usage). Patient had the following side effects: diarrhoea, therapeutic agent toxicity. Lithium dosage: . During the same period patient was treated with XENICAL (360mg Per Day) (View Xenical Review and Xenical Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ).

5473736-1 | Loss Of Consciousness, Weight Increased
Patient was taking Lithium (View Usage). After Lithium was administered, patient had the following side effects: loss of consciousness, weight increased on Mar 04, 2004 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with schizoaffective disorder and. Lithium dosage: . During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), CLOZARIL (View Clozaril Review and Clozaril Label ), DEXEDRINE (View Dexedrine Review and Dexedrine Label ). Patient was hospitalized.

5449879-5 | Arthropathy, Blood Glucose Decreased, Convulsion, Diabetes Mellitus, Dysphagia, Dyspnoea, Muscular Weakness
Adverse event was reported on Sep 07, 2007 by a Female patient taking Lithium (View Usage) (Dosage: 300 Mg Twice A Day) was diagnosed with bipolar disorder (What is bipolar disorder?), bipolar i disorder and. Location: UNITED STATES , 41 years of age, weighting 230.0 lb, Patient experienced the following unwanted or unexpected effects: arthropathy, blood glucose decreased, convulsion, diabetes mellitus, dysphagia, dyspnoea, muscular weakness. During the same period patient was treated with HALDOL (One Sh) (View Haldol Review and Haldol Label ), RISPERDAL (3 Mg Twice A Day) (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5370805-1 | Amenorrhoea, Oligomenorrhoea, Suicide Attempt
on Jun 19, 2007 Female patient from UNITED KINGDOM , 31 years of age, was treated with Lithium (View Usage). Patient had the following side effects: amenorrhoea, oligomenorrhoea, suicide attempt. Lithium dosage: . During the same period patient was treated with DEPO PROVERA (View Depo-provera Review and Depo-provera Label ).

5163650-3 | Confusional State, Dehydration, Mental Status Changes, Nervous System Disorder, Pneumonia Aspiration, Therapeutic Agent Toxicity
on Nov 27, 2006 Female patient from UNITED STATES , 54 years of age, was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: confusional state, dehydration, mental status changes, nervous system disorder, pneumonia aspiration, therapeutic agent toxicity. Lithium dosage: 600 Mg Bid Po. During the same period patient was treated with MAXZIDE (View Maxzide Review and Maxzide Label ), AVANDIA (View Avandia Review and Avandia Label ), REGLAN (View Reglan Review and Reglan Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

5117169-6 | Mental Status Changes, Renal Failure
Patient was taking Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: mental status changes, renal failure on Sep 27, 2006 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 319.7 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Lithium dosage: 1200mg Qhs Po. Patient was hospitalized.

5117153-2 | Renal Failure
Adverse event was reported on Sep 27, 2006 by a Male patient taking Lithium (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 64 years of age, weighting 134.5 lb, Patient had the following side effects: renal failure.

5082487-7 | Cholecystitis, Escherichia Sepsis, Leukocytosis, Malaise, Pyrexia, Septic Shock
on Aug 14, 2006 Female patient from NETHERLANDS , 86 years of age, weighting 143.3 lb, was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: cholecystitis, escherichia sepsis, leukocytosis, malaise, pyrexia, septic shock. Lithium dosage: 200 Mg, Qd. During the same period patient was treated with DIAZEPAM (1.25 Mg, Qd) (View Diazepam Review and Diazepam Label ), MOVICOLON (1 Df, Qd) (View Movicolon Review and Movicolon Label ), LACTULOSE (30 Mg, Bid) (View Lactulose Review and Lactulose Label ), LEPONEX (100 Mg, Bid) (View Leponex Review and Leponex Label ), ASCAL CARDIO (100 Mg, Qd) (View Ascal Cardio Review and Ascal Cardio Label ), SUPRADYN (100 Mg, Qd) (View Supradyn Review and Supradyn Label ), MULTIVITAMIN (1 Df, Qd) (View Multivitamin Review and Multivitamin Label ). Patient was hospitalized.

5073502-5 | Bile Duct Stone, Cholelithiasis, Cholestasis, Liver Function Test Abnormal, Renal Cyst, Suicide Attempt, Tooth Abscess
on Jul 07, 2006 Male patient from SWITZERLAND , 51 years of age, weighting 202.8 lb, was diagnosed with schizophrenia, paranoid type and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: bile duct stone, cholelithiasis, cholestasis, liver function test abnormal, renal cyst, suicide attempt, tooth abscess. Lithium dosage: 1200 Mg/d. During the same period patient was treated with CLOZAPINE (500 Mg/d) (View Clozapine Review and Clozapine Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLAVULANIC ACID (View Clavulanic Acid Review and Clavulanic Acid Label ), TRICHLOROETHYLENE (0.5 L, Once/single) (View Trichloroethylene Review and Trichloroethylene Label ).

5066484-3 | Chest Discomfort, Dehydration, Diarrhoea, Fluid Intake Reduced, Ileus, Nausea, Renal Failure Acute
Patient was taking Lithium (View Usage). Patient had the following side effects: chest discomfort, dehydration, diarrhoea, fluid intake reduced, ileus, nausea (What is nausea?), renal failure acute on Jul 31, 2006 from UNITED STATES Additional patient health information: Female patient , 46 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Lithium dosage: . During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), TRIFLUOPERAZINE HCL (View Trifluoperazine Hcl Review and Trifluoperazine Hcl Label ), LUNESTA (View Lunesta Review and Lunesta Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), COMBIVENT (View Combivent Review and Combivent Label ), AVELOX (View Avelox Review and Avelox Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5061278-7 | Syncope
Adverse event was reported on Jul 19, 2006 by a Female patient taking Lithium (View Usage) (Dosage: 300 Mg Tid) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 30 years of age, After Lithium was administered, patient had the following side effects: syncope. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

5061078-8 | Confusional State, Depressed Level Of Consciousness, Therapeutic Agent Toxicity, Unresponsive To Stimuli
on Jul 19, 2006 Female patient from UNITED STATES , 50 years of age, was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, depressed level of consciousness, therapeutic agent toxicity, unresponsive to stimuli. Lithium dosage: 600 Mg Po Bid. Patient was hospitalized.

5017504-3 | Therapeutic Agent Toxicity, Tremor
on Jun 01, 2006 Male patient from UNITED STATES , 61 years of age, weighting 177.9 lb, was treated with Lithium (View Usage). Patient had the following side effects: therapeutic agent toxicity, tremor. Lithium dosage: . Patient was hospitalized.

4990271-5 | Autoimmune Thyroiditis, Blood Thyroid Stimulating Hormone Increased, Condition Aggravated, Hypothyroidism, Mania
Patient was taking Lithium (View Usage). After Lithium was administered, patient had the following side effects: autoimmune thyroiditis, blood thyroid stimulating hormone increased, condition aggravated, hypothyroidism, mania on Sep 09, 2004 from FRANCE Additional patient health information: Female patient , 30 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Lithium dosage: .

4980274-9 | Therapeutic Agent Toxicity
Adverse event was reported on Apr 20, 2006 by a Male patient taking Lithium (View Usage) (Dosage: ) . Location: UNITED STATES , 26 years of age, weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: therapeutic agent toxicity. During the same period patient was treated with CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), LORATADINE (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

4954102-1 | Abasia, Agitation, Alanine Aminotransferase Increased, Aphasia, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Iron Decreased, Blood Potassium Abnormal
on Mar 13, 2006 Male patient from UNITED STATES , 47 years of age, was treated with Lithium (View Usage). Patient had the following side effects: abasia, agitation, alanine aminotransferase increased, aphasia (What is aphasia?), aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood iron decreased, blood potassium abnormal. Lithium dosage: 450mg Twice Per Day. During the same period patient was treated with ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), DIVALPROEX SODIUM (View Divalproex Sodium Review and Divalproex Sodium Label ), LOSARTAN POTASSIUM (100mg Per Day) (View Losartan Potassium Review and Losartan Potassium Label ), IBUPROFEN (800mg Three Times Per Day) (View Ibuprofen Review and Ibuprofen Label ), FUROSEMIDE (40mg Per Day) (View Furosemide Review and Furosemide Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), ACETAMINOPHEN (650mg Three Times Per Day) (View Acetaminophen Review and Acetaminophen Label ), IPRATROPIUM BROMIDE (2puff Four Times Per Day) (View Ipratropium Bromide Review and Ipratropium Bromide Label ). Patient was hospitalized.

4947809-3 | Diabetes Insipidus, Diabetic Ketoacidosis, Disease Recurrence, Psychotic Disorder, Weight Increased
on Mar 11, 2006 Female patient from UNITED KINGDOM , 51 years of age, was diagnosed with schizophrenia, hypothyroidism, hyperlipidaemia, coronary artery disease (What is coronary artery disease?), hypertension and was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), diabetic ketoacidosis, disease recurrence, psychotic disorder (What is psychotic disorder?), weight increased. Lithium dosage: . During the same period patient was treated with QUETIAPINE (400mg Per Day) (View Quetiapine Review and Quetiapine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

4945347-5 | Asthenia, Confusional State, Dehydration, Feeling Abnormal, Gait Disturbance, Hunger, Renal Impairment, Therapeutic Agent Toxicity, Thirst
Patient was taking Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, confusional state, dehydration, feeling abnormal, gait disturbance, hunger, renal impairment, therapeutic agent toxicity, thirst on Mar 15, 2006 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 157.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Lithium dosage: 300mg Po Tid. During the same period patient was treated with FLUPHENAZINE (View Fluphenazine Review and Fluphenazine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

4945343-8 | Atrioventricular Block Second Degree, Dizziness, Palpitations, Syncope
Adverse event was reported on Mar 15, 2006 by a Male patient taking Lithium (View Usage) (Dosage: 300mg Po Bid) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 56 years of age, weighting 216.1 lb, Patient had the following side effects: atrioventricular block second degree, dizziness (What is dizziness?), palpitations, syncope. During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

4945340-2 | Asthenia, Urinary Tract Infection
on Mar 15, 2006 Male patient from UNITED STATES , 59 years of age, weighting 150.4 lb, was diagnosed with schizoaffective disorder and was treated with Lithium (View Usage). After Lithium was administered, patient had the following side effects: asthenia, urinary tract infection (What is urinary tract infection?). Lithium dosage: 450mg Po Bid. Patient was hospitalized.

4931993-1 | Acute Prerenal Failure, Bradycardia, Bradykinesia, Confusional State, Delirium, Difficulty In Walking, Disorientation, Dyskinesia
on Dec 20, 2005 Female patient from TURKEY , 62 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?), hallucination, insomnia and was treated with Lithium (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, bradycardia, bradykinesia, confusional state, delirium, difficulty in walking, disorientation, dyskinesia. Lithium dosage: 900mg Per Day. During the same period patient was treated with OLANZAPINE (5mg Per Day) (View Olanzapine Review and Olanzapine Label ), CHLORPROMAZINE (200mg Per Day) (View Chlorpromazine Review and Chlorpromazine Label ). Patient was hospitalized.

4918278-4 | Lethargy
Patient was taking Lithium (View Usage). Patient had the following side effects: lethargy on Feb 17, 2006 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 162.0 lb, . Lithium dosage: .